Wörwag Pharma GmbH & Co. KG
Dr. David Eberle has over 15 years of work experience in the pharmaceutical industry. Dr. David has served as the Head of Quality Assurance and Qualified Person at Wörwag Pharma GmbH & Co. KG, where they were responsible for tasks such as batch release, complaint handling, and audits. Prior to this, they worked as the Head of QA Release Sterile Cephalosporins at Sandoz, overseeing the quality assurance of sterile products. Dr. David also served as the Head of Laboratory at Merz Pharma, managing chromatography and microbiology labs. Dr. Eberle began their career as an Apotheker at Adelsbach Apotheke.
Dr. David Eberle completed their education with two degrees from Phillips-Universität Marburg. From 1998 to 2002, they pursued a degree in Pharmazie and obtained a Staatsexamen. Later, they enrolled in the Institut für Pharmazeutische Biologie at Phillips-Universität Marburg from 2004 to 2008, completing their Dr. rer. nat. in that field of study.
This person is not in the org chart
This person is not in any teams
Wörwag Pharma GmbH & Co. KG
Woerwag Pharma GmbH & Co. KG is a family-owned and international operating pharmaceutical company headquartered in Boeblingen, Germany, developing and selling biofactor preparations wordwide with more than 1400 employees in 35 countries. The company’s product rage is exclusively available in pharmacies and includes both prescription preparations as well as over the counter (OTC) products and food supplements. Therapeutic areas focus on diabetic comorbidities, diseases of the nervous system, of the musculoskeletal system, as well as on stabilizing the immune system.